Goat CAV3 / Caveolin 3 Polyclonal Antibody | anti-CAV3 antibody

Goat Polyclonal to Human CAV3 / Caveolin 3

Cat. Num. AAA247336

• Gene Names: CAV3; LQT9; VIP21; LGMD1C; VIP-21
• Reactivity: Gibbon, Bovine, Dog, Gorilla, Horse, Human, Monkey; Predicted Reactivity: Bat, Pig, Rabbit (at least 90% immunogen sequence identity)
• Applications: Immunohistochemistry, Western Blot, ELISA
• Purity: Immunoaffinity Purified
• Synonyms: CAV3 / Caveolin 3; Polyclonal Antibody; Goat Polyclonal to Human CAV3 / Caveolin 3; Anti-CAV3 / Caveolin 3 Antibody (N-Terminus) IHC-plus; CAV3; Caveolin-3; Caveolin3; Caveolin 3; LGMD1C; VIP-21; VIP21; LQT9; M-caveolin; Human CAV3; anti-CAV3 antibody

• Host: Goat
• Reactivity: Gibbon, Bovine, Dog, Gorilla, Horse, Human, Monkey; Predicted Reactivity: Bat, Pig, Rabbit (at least 90% immunogen sequence identity)
• Clonality: Polyclonal
• Specificity: Human CAV3 / Caveolin 3. Reported variants represent identical protein (NP_001225.1; NP_203123.1).
• Purity/Purification: Immunoaffinity Purified
• Form/Format: Tris-buffered saline, pH 7.3, 0.5% BSA, 0.02% sodium azide
• Concentration: 0.5 mg/ml (varies by lot)
• Sequence Length: 151

• Applicable Applications for anti-CAV3 antibody: Immunohistochemistry (IHC - Paraffin), Western Blot (WB), ELISA (EIA)
• Application Notes: ELISA (1:4000), IHC-P (3.75 ug/ml), WB (0.3 - 1 ug/ml); Usage: Peptide ELISA: antibody detection limit dilution 1:4000. Western blot: Approx. 23kDa band observed in Human, Mouse and Rat Heart lysates (calculated MW of 17.3kDa according to NP_203123.1). The observed molecular weight corresponds to earlier finding...
• Target Species: Human
• Immunogen Description: Synthetic peptide EHTDLEAQIVKDIH-C from the N-terminus of human CAV3 / Caveolin 3 (NP_203123.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Panda, Dog, Bovine, Horse (100%); Bat, Rabbit, Pig (93%); Mouse, Rat (86%).
• Immunogen Type: Synthetic peptide
• Immunogen: CAV3 / Caveolin 3 antibody was raised against synthetic peptide EHTDLEAQIVKDIH-C from the N-terminus of human CAV3 / Caveolin 3 (NP_203123.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Panda, Dog, Bovine, Horse (100%); Bat, Rabbit, Pig (93%); Mouse, Rat (86%).
• Antigen Modification: N-Terminus
• Preparation and Storage: Store at -20 degree C. Minimize freezing and thawing.

Immunohistochemistry (IHC)

(Anti-Caveolin 3 antibody IHC of human skeletal muscle. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody dilution 3.75 ug/ml.)

Western Blot (WB)

(CAV3 antibody (0.3 ug/ml) staining of Human Heart lysate (35 ug protein/ml in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.)

Related Product Information for anti-CAV3 antibody

Caveolin proteins are components of caveolae plasma membranes found in most cell types. Caveolin-3 is the muscle-specific form of the caveolin protein family whose members are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules within the caveolae membranes. Mutations in caveolin-3 have been isolated which interfere with caveolin-3 oligomerization and disrupt caveolae formation resulting in limb-girdle muscular dystrophy.

NCBI and Uniprot Product Information

• NCBI GI #: 4502589
• NCBI GeneID: 859
• NCBI Accession #: NP_001225.1
• NCBI GenBank Nucleotide #: NM_001234.4
• UniProt Accession #: P56539; Q3T1A4; A8K777
• Molecular Weight: 17,259 Da
• NCBI Official Full Name: caveolin-3
• NCBI Official Synonym Full Names: caveolin 3
• NCBI Official Symbol: CAV3
• NCBI Official Synonym Symbols: LQT9; VIP21; LGMD1C; VIP-21
• NCBI Protein Information: caveolin-3; M-caveolin
• UniProt Protein Name: Caveolin-3
• Protein Family: Caveolin
• UniProt Gene Name: CAV3
• UniProt Entry Name: CAV3_HUMAN

NCBI Description

This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008]

Uniprot Description

caveolin-3: May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. May also regulate voltage-gated potassium channels. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress. Defects in CAV3 are the cause of limb-girdle muscular dystrophy type 1C (LGMD1C). LGMD1C is a myopathy characterized by calf hypertrophy and mild to moderate proximal muscle weakness. LGMD1C inheritance can be autosomal dominant or recessive. Defects in CAV3 are a cause of hyperCKmia (HYPCK). It is a disease characterized by persistent elevated levels of serum creatine kinase without muscle weakness. Defects in CAV3 are a cause of rippling muscle disease (RMD). RMD is a rare disorder characterized by mechanically triggered contractions of skeletal muscle. In RMD, mechanical stimulation leads to electrically silent muscle contractions that spread to neighboring fibers that cause visible ripples to move over the muscle. Defects in CAV3 are a cause of familial hypertrophic cardiomyopathy (CMH); also designated FHC or HCM. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Defects in CAV3 are the cause of long QT syndrome type 9 (LQT9). Long QT syndromes are heart disorders characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to excercise or emotional stress. They can present with a sentinel event of sudden cardiac death in infancy. Defects in CAV3 can be a cause of sudden infant death syndrome (SIDS). SIDS is the sudden death of an infant younger than 1 year that remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of clinical history. Pathophysiologic mechanisms for SIDS may include respiratory dysfunction, cardiac dysrhythmias, cardiorespiratory instability, and inborn errors of metabolism, but definitive pathogenic mechanisms precipitating an infant sudden death remain elusive. Long QT syndromes-associated mutations can be responsible for some SIDS cases. Defects in CAV3 are the cause of myopathy distal Tateyama type (MPDT). A disorder characterized by progressive muscular atrophy and muscle weakness beginning in the hands, the legs, or the feet. Muscle atrophy may be restricted to the small muscles of the hands and feet. Belongs to the caveolin family.

Protein type: Dystrophin complex; Cell development/differentiation; Motility/polarity/chemotaxis; Extracellular matrix

Chromosomal Location of Human Ortholog: 3p25

Cellular Component: dystrophin-associated glycoprotein complex; Golgi membrane; cell surface; endoplasmic reticulum; T-tubule; plasma membrane; caveola; Z disc; neuromuscular junction; vesicle; sarcolemma; lipid raft

Molecular Function: protein C-terminus binding; protein binding; sodium channel regulator activity; calcium channel regulator activity; protein complex binding; protein complex scaffold; potassium channel inhibitor activity; nitric-oxide synthase binding; alpha-tubulin binding

Biological Process: negative regulation of MAP kinase activity; muscle development; T-tubule organization and biogenesis; positive regulation of microtubule polymerization; negative regulation of cell size; glucose homeostasis; cytoplasmic microtubule organization and biogenesis; regulation of heart contraction; muscle maintenance; elevation of cytosolic calcium ion concentration; protein localization; cardiac muscle cell development; regulation of transforming growth factor beta receptor signaling pathway; plasma membrane organization and biogenesis; positive regulation of cell proliferation; regulation of skeletal muscle contraction; cell growth; cell differentiation; regulation of nerve growth factor receptor activity; myoblast fusion; negative regulation of calcium ion transport; negative regulation of nitric-oxide synthase activity; regulation of heart rate; negative regulation of MAPKKK cascade; actin filament organization; endocytosis; regulation of protein kinase B signaling cascade; nucleus localization; cholesterol homeostasis; regulation of membrane potential; triacylglycerol metabolic process; plasma membrane repair; negative regulation of protein kinase activity; lipid raft organization and biogenesis

Disease: Creatine Phosphokinase, Elevated Serum; Rippling Muscle Disease; Long Qt Syndrome 9; Muscular Dystrophy, Limb-girdle, Type 1c; Myopathy, Distal, Tateyama Type; Cardiomyopathy, Familial Hypertrophic, 1